Lagneaux L - Search Results

1

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Id Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F. Id Boufker H, et al. Among authors: lagneaux l. BMC Cancer. 2010 Jun 17;10:298. doi: 10.1186/1471-2407-10-298. BMC Cancer. 2010. PMID: 20565769 Free PMC article.

2

Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.

Lagneaux L, Delforge A, Snoeck R, Stryckmans P, Bron D. Lagneaux L, et al. Exp Hematol. 1994 Jan;22(1):26-30. Exp Hematol. 1994. PMID: 7506672

3

The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11.

Sotiriou C, Lacroix M, Lagneaux L, Berchem G, Body JJ. Sotiriou C, et al. Among authors: lagneaux l. Anticancer Res. 1999 Jul-Aug;19(4B):2997-3006. Anticancer Res. 1999. PMID: 10652584

4

Bisphosphonates induce breast cancer cell death in vitro.

Fromigue O, Lagneaux L, Body JJ. Fromigue O, et al. Among authors: lagneaux l. J Bone Miner Res. 2000 Nov;15(11):2211-21. doi: 10.1359/jbmr.2000.15.11.2211. J Bone Miner Res. 2000. PMID: 11092402 Free article.

5

Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.

Dumon JC, Journé F, Kheddoumi N, Lagneaux L, Body JJ. Dumon JC, et al. Among authors: lagneaux l. Eur Urol. 2004 Apr;45(4):521-8; discussion 528-9. doi: 10.1016/j.eururo.2003.12.012. Eur Urol. 2004. PMID: 15041119

6

Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation.

Tondreau T, Lagneaux L, Dejeneffe M, Massy M, Mortier C, Delforge A, Bron D. Tondreau T, et al. Among authors: lagneaux l. Differentiation. 2004 Sep;72(7):319-26. doi: 10.1111/j.1432-0436.2004.07207003.x. Differentiation. 2004. PMID: 15554943

7

Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential.

Tondreau T, Lagneaux L, Dejeneffe M, Delforge A, Massy M, Mortier C, Bron D. Tondreau T, et al. Among authors: lagneaux l. Cytotherapy. 2004;6(4):372-9. doi: 10.1080/14653240410004943. Cytotherapy. 2004. PMID: 16146890

8

Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner.

Cardoso F, Durbecq V, Laes JF, Badran B, Lagneaux L, Bex F, Desmedt C, Willard-Gallo K, Ross JS, Burny A, Piccart M, Sotiriou C. Cardoso F, et al. Among authors: lagneaux l. Mol Cancer Ther. 2006 Dec;5(12):3042-51. doi: 10.1158/1535-7163.MCT-06-0104. Epub 2006 Dec 5. Mol Cancer Ther. 2006. PMID: 17148762

9

Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells.

Tondreau T, Dejeneffe M, Meuleman N, Stamatopoulos B, Delforge A, Martiat P, Bron D, Lagneaux L. Tondreau T, et al. Among authors: lagneaux l. BMC Genomics. 2008 Apr 11;9:166. doi: 10.1186/1471-2164-9-166. BMC Genomics. 2008. PMID: 18405367 Free PMC article.

10

In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.

Tondreau T, Meuleman N, Stamatopoulos B, De Bruyn C, Delforge A, Dejeneffe M, Martiat P, Bron D, Lagneaux L. Tondreau T, et al. Among authors: lagneaux l. Cytotherapy. 2009;11(5):559-69. doi: 10.1080/14653240903051541. Cytotherapy. 2009. PMID: 19551542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters